盐酸丙酰左卡尼汀片在中国健康受试者的开放、单臂、自身对照、三周期递增单次给药的安全性和药代动力学研究
[Translation] An open-label, single-arm, self-controlled, three-cycle ascending single-dose safety and pharmacokinetic study of propionyl-L-carnitine hydrochloride tablets in healthy Chinese subjects
用于评价盐酸丙酰左卡尼汀片在中国健康受试者中单次给药的临床药代动力学特征和安全性,为药物上市注册提供依据。
[Translation] To evaluate the clinical pharmacokinetic characteristics and safety of single-dose propionyl-L-carnitine hydrochloride tablets in Chinese healthy subjects, and to provide a basis for drug marketing registration.
盐酸丙酰左卡尼汀片在中国健康受试者中的开放、单臂、自身对照饮食影响及多次给药的安全性和药代动力学研究
[Translation] An open-label, single-arm, self-controlled dietary effect and multiple-dose safety and pharmacokinetic study of propionyl-L-carnitine hydrochloride tablets in healthy Chinese subjects
用于评价进食对盐酸丙酰左卡尼汀片临床药代动力学特征的影响,以及盐酸丙酰左卡尼汀片在中国健康受试者中多次给药的临床药代动力学特征和安全性,为药物上市依据。
[Translation] To evaluate the effect of food intake on the clinical pharmacokinetic characteristics of Propionyl-L-Carnitine Hydrochloride Tablets, and the clinical pharmacokinetic characteristics and clinical pharmacokinetic characteristics of Propionyl-L-Carnitine Hydrochloride Tablets after multiple administrations in healthy Chinese subjects. Safety is the basis for drug listing.
100 Clinical Results associated with Hefei Zhaofeng Keda Pharmaceutical Co., Ltd. Guangzhou Branch
0 Patents (Medical) associated with Hefei Zhaofeng Keda Pharmaceutical Co., Ltd. Guangzhou Branch
100 Deals associated with Hefei Zhaofeng Keda Pharmaceutical Co., Ltd. Guangzhou Branch
100 Translational Medicine associated with Hefei Zhaofeng Keda Pharmaceutical Co., Ltd. Guangzhou Branch